Page last updated: 2024-10-29

iodixanol and Reperfusion Injury

iodixanol has been researched along with Reperfusion Injury in 1 studies

iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.

Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.

Research Excerpts

ExcerptRelevanceReference
"In iohexol-treated LLC-PK1 cells, rhEpo attenuated activation of caspase-3 (p = 0."1.35Protective effect of erythropoietin against radiocontrast-induced renal tubular epithelial cell injury. ( Jaber, BL; Kolyada, AY; Liangos, O; Madias, NE, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kolyada, AY1
Liangos, O1
Madias, NE1
Jaber, BL1

Other Studies

1 other study available for iodixanol and Reperfusion Injury

ArticleYear
Protective effect of erythropoietin against radiocontrast-induced renal tubular epithelial cell injury.
    American journal of nephrology, 2008, Volume: 28, Issue:2

    Topics: Animals; Apoptosis; Caspases; Cell Survival; Contrast Media; Enzyme Activation; Epithelial Cells; Er

2008